Business

Announcement on Voluntary Disclosure of Obtaining Zanzibar Drug Registration Certificate for Ainuovirine, Lamivudine and Tenofovir Disoproxil Fumarate Tablets

Announcement on Voluntary Disclosure of Obtaining Zanzibar Drug Registration Certificate for Ainuovirine, Lamivudine and Tenofovir Disoproxil Fumarate Tablets

articleJiangsu Aidea Pharmaceutical Group Co., Ltd. Class AJuly 27, 20254/news/announcement-on-voluntary-disclosure-of-obtaining-zanzibar-drug-registration-certificate-for-ainuovirine-lamivudine-and-tenofovir-disoproxil-fumarate-tablets
Announcement on Voluntary Disclosure of Obtaining Zanzibar Drug Registration Certificate for Ainuovirine, Lamivudine and Tenofovir Disoproxil Fumarate Tablets

About this update from Jiangsu Aidea Pharmaceutical Group Co., Ltd. Class A

Announcement on Voluntary Disclosure of Obtaining Zanzibar Drug Registration Certificate for Ainuovirine, Lamivudine and Tenofovir Disoproxil Fumarate TabletsThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Jiangsu Aidea Pharmaceutical Group Co., Ltd. Class A